Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

December 30, 2025

Conditions
Opioid Use Disorder
Interventions
COMBINATION_PRODUCT

Hyperbaric Oxygen Treatment Full

Participants in this active treatment arm of the protocol will receive Hyperbaric Oxygen Treatment (HBOT)100% oxygen and 2.0 ATA prior to and the day of medically supervised 5% methadone dose reductions while sitting in a wheelchair-accessible, multi-place sealed pressurized chamber for 90 minutes each session.

COMBINATION_PRODUCT

Hyperbaric Oxygen Treatment Sham

Participants in the sham condition arm of the protocol will receive Hyperbaric Oxygen Treatment (HBOT) 21% oxygen and 1.3 ATA prior to and the day of medically supervised 5% methadone dose reductions while sitting in a wheelchair-accessible, multi-place sealed pressurized chamber for 90 minutes each session receiving less than a fully pressurized 100% oxygen dose.

COMBINATION_PRODUCT

Hyperbaric Oxygen Treatment Partial Pressure

Participants in this partial treatment arm of the protocol will receive Hyperbaric Oxygen Treatment (HBOT)100% oxygen and 1.3 ATA prior to and the day of medically supervised 5% methadone dose reductions while sitting in a wheelchair-accessible, multi-place sealed pressurized chamber for 90 minutes each session.

Trial Locations (1)

99201

Spokane Regional Health District, Spokane

All Listed Sponsors
lead

Washington State University

OTHER

NCT05924022 - Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering | Biotech Hunter | Biotech Hunter